ClinicalTrials.Veeva

Menu

D2 vs D3 Lymph Node Dissection for Left Colon Cancer (DILEMMA)

R

Russian Society of Colorectal Surgeons

Status

Enrolling

Conditions

Colon Cancer

Treatments

Procedure: Sigmoid colon resection
Procedure: Distal sigmoid colon resection or anterior resection
Procedure: Left colon resection

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.

Full description

Discussion about optimal type of lymph node dissection in colorectal cancer continues during last 15 years, when in Europe was presented concept of complete mesocolic excision. However, this concepts is very close to Japanese D3 lymph node dissection and in the first view it seems the same but principal differences were found. Japanese concept is partial resection of the bowel according feeding artery (short bowel specimen, long lymphovascular pedicle), opposite European concept is wide resection of the bowel like hemicolectomy or extended hemicolectomy, sigmoidectomy. In complete mesocolic excision anatomical landmarks are still unclear but in Japanese guidelines it has anatomical margins which can standardize this procedure. Also nerve sparing technique around root of inferior mesenteric artery was described. One more difference is in histological examination of the specimen. European concept is to pay more attention to the quality of complete mesocolic excision and less - to the number of investigated lymph nodes. In Japan lymph node extraction is performed by surgical team from the fresh specimen and send to pathologist separately (each group of lymph nodes). Considering the absence of randomized control trials for patients with left colon cancer DILEMMA trial was started using Japanese approach

Enrollment

1,381 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Agreement of the patient to participate in trial
  2. Colon cancer (only adenocarcinoma )
  3. The tumor located between the splenic flexure and rectosigmoid junction
  4. cT3-Т4а,b
  5. cN0-2
  6. cM0
  7. Tolerance of chemotherapy
  8. ASA 1-3

Exclusion criteria

  1. сТis - Т2, сТ4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder)
  2. Preoperative complications of the tumor (perforation and full bowel 3. obstruction)
  3. Previous radiotherapy or chemotherapy
  4. Synchronous or metachronous tumors
  5. Women during Pregnancy or breast feeding period

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,381 participants in 2 patient groups

D2 lymph node dissection
Active Comparator group
Description:
For tumours in splenic flexure and proximal and mid part of descending colon lymph nodes 232 and 231 will be removed. For tumours in distal part of descending colon and proximal sigmoid lymph nodes 231, 232 and partially 241, 242 (considering variation of the feeding artery) will be removed. For tumours in the mid part of sigmoid colon lymph nodes 241, 242 will be removed. For tumours in the rectosigmoid junction 251, 252 groups of the lymph node will be removed.
Treatment:
Procedure: Sigmoid colon resection
Procedure: Left colon resection
Procedure: Distal sigmoid colon resection or anterior resection
D3 lymph node dissection
Experimental group
Description:
For tumours in splenic flexure and proximal and mid part of descending colon lymph nodes 232, 231 and 253 will be removed. For tumours in distal part of descending colon and proximal sigmoid lymph nodes 231, 232 and 253 and partially 241, 242 (considering variation of the feeding artery) will be removed. For tumours in the mid part of sigmoid colon lymph nodes 241, 242 and 253 will be removed. For tumours in the rectosigmoid junction 251, 252 and 253 groups of the lymph node will be removed.
Treatment:
Procedure: Sigmoid colon resection
Procedure: Left colon resection
Procedure: Distal sigmoid colon resection or anterior resection

Trial contacts and locations

1

Loading...

Central trial contact

Inna Tulina, Ph.D; Vladimir Balaban, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems